Article
Epidermal growth factor receptor regulates lineage plasticity driving transformation to small cell lung cancer.
Biochemical and biophysical research communications - 12 Nov 2023
Jing Meng, He Xia, Cai Cheng Zhi, Ma Qi Zhi, Li Kai, Zhang Ben Xia, Yin Yuan, Shi Ming Song, Wang Yong Sheng
Abstract excerpt
Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) is clinically and genetically heterogeneous, with concurrent RB1/TP53 mutations, indicating an increased risk of transformation into small cell lung cancer (SCLC). When tumor cells convert into a different histological subtype, they lose their dependence on the original oncogenic driver, resulting in therapeutic resistance. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
